New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2014
09:34 EDTTRIP, AAPL, CTRX, AMZN, TSLA, NFLXActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL TSLA AMZN CTRX TRIP NFLX
News For NFLX;AMZN;AAPL;TSLA;CTRX;TRIP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | all recent news | >>
April 6, 2015
13:12 EDTCTRXCatamaran purchase expected to clear antitrust hurdles, CT Financial News says
Optum, a unit of UnitedHealth (UNH), is expected to face close scrutiny by regulators over its proposed acquisition of Catamaran (CTRX) and its pharmacy benefits management unit, but the deal is likely to be approved by regulators, CT Financial News reports, adding that the prospective deal could start a wave of consolidation among PBMs. Norm Smith, president and founder of health care research firm Viewpoint Consulting, believes the ultimate beneficiaries of the OptumRx/Catamaran deal will be consumers and health insurers. Reference Link
12:44 EDTTSLAOn The Fly: Midday Wrap
Subscribe for More Information
12:31 EDTTSLAStreet Check: Credit Suisse confidence in Tesla Q1 deliveries warranted
The shares of Tesla are rising after the electric automaker announced Friday that it had delivered 10,030 vehicles last quarter, significantly above the company's guidance of 9,500 and representing a 55% increases versus the same period a year earlier. In a note to investors on April 2, Credit Suisse analyst Dan Galves predicted that Tesla's could exceed its guidance for Q1 sales. The Fly published a summary of Credit Suisse's note on that day, as shown in the link below. WHAT HAPPENED: Preliminary data on March order trends indicated that demand for Tesla's vehicles in Europe was rising significantly, Galves reported on April 2. The addition of all-wheel drive capabilities to Tesla's cars probably made the vehicles more appealing to northern European consumers, the analyst stated, adding that this growth should enable the company's Q1 deliveries to come in above its guidance, partly because the company did not appear to have experienced supply issues last quarter as it had over the previous two years. Galves kept a $290 price target and Outperform rating on the shares. ANALYSTS' OUTLOOK: On April 2, Galves expressed optimism about Tesla's Q2 orders, predicting that a full quarter of all-wheel drive vehicle sales would drive growth in Europe over Q1, while more production weeks and better leasing options should spur strong sales in the U.S. After Tesla announced its Q1 deliveries, research firm Robert W. Baird was upbeat on the stock, continuing to identify the name as its favorite pick. Baird kept a $275 price target and Outperform rating on the shares. Conversely, BofA Merrill Lynch said Tesla's Q1 deliveries of 10,030 vehicles is not impressive and only represents 2% sequential growth. The firm questions Tesla's "disruptive growth" and believes the company will have difficulty reaching its FY15 target of 55K vehicles. Merrill Lynch has an Underperform rating with a $65 price target on Tesla shares. WHAT'S NOTABLE: In a note to investors on March 31, Goldman Sachs wrote that the outlook for Tesla's stock had improved in the wake of the 33% decline in its shares since September 2014. Concerns about competition in the electric vehicle market was overblown, while Tesla is likely to disrupt the auto market, according to the firm, which kept a $214 price target and Hold rating on the shares, but added that the stock could exceed that target. The Fly published a summary of Goldman's note on March 31. PRICE ACTION: In early afternoon trading, Tesla jumped $14.30, or 7.5%, to $205 per share. Reference Link
11:11 EDTCTRXOptions with decreasing implied volatility
Options with decreasing implied volatility: BDSI CONN HLSS CTRX DANG ARCP KMX MAC
10:23 EDTTRIP, AAPLApple Maps searches no longer showing just Yelp, AppleInsider reports
Searches on Apple (AAPL) Maps, which previously relied solely on Yelp (YELP) to provide reviews for local search, are now pulling results from TripAdvisor (TRIP) and Priceline's (PCLN) Booking.com, AppleInsider reported yesterday. Neither TripAdvisor or Booking.com are listed as sources on Apple's official Maps attribution webpage, but reviews with links to their respective webpages and apps are now appearing in Maps queries, the blog added. Shares of Yelp are down 1% to $46.67 in early trading. Reference Link
10:15 EDTTSLATesla breaks higher, levels to watch
Subscribe for More Information
10:02 EDTTRIP, CTRXOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AGCO (AGCO) downgraded to Sell from Hold at Deutsche Bank... CONSOL (CNX) downgraded to Hold from Buy at Deutsche Bank... Catamaran (CTRX) downgraded to Market Perform from Outperform at BMO Capital... Comerica (CMA) downgraded to Neutral from Buy at Guggenheim... Gannett (GCI) downgraded to Market Perform from Outperform at FBR Capital... Magnum Hunter (MHR) downgraded to Hold from Buy at Wunderlich... Qualcomm (QCOM) downgraded to Market Perform from Outperform at FBR Capital... Regions Financial (RF) downgraded to Neutral from Buy at Guggenheim... SAP (SAP) downgraded at Wells Fargo... Sanderson Farms (SAFM) downgraded to Underweight from Sector Weight at KeyBanc... Scorpio Tankers (STNG) downgraded to Neutral from Accumulate at Global Hunter... Simpson Manufacturing (SSD) downgraded to Neutral from Buy at DA Davidson... Skyworks (SWKS) downgraded at Stephens... TripAdvisor (TRIP) downgraded to Hold from Buy at Needham... Western Union (WU) downgraded to Neutral from Positive at Susquehanna... Zillow Group (Z) downgraded to Equal Weight from Overweight at Barclays.
09:36 EDTAAPL, TSLAActive equity options trading on open
Subscribe for More Information
09:25 EDTAMZNeBay threatened by merchant satisfaction with Amazon, Bloomberg says
Subscribe for More Information
09:22 EDTTSLAOn The Fly: Pre-market Movers
HIGHER: Uniqure (QURE), up 44.2% following strategic collaboration with Bristol-Myers (BMY)... Cytori Therapeutics (CYTX), up 22.4% after Lorem Vascular receives regulatory clearance in China... Curis (CRIS), up 8.5% after FDA grants orphan drug designation to CUDC-907 for the treatment of Diffuse Large B-Cell Lymphoma... Capnia (CAPN), up 5.9% after being awarded a $220,000 NIH grant... Tesla (TSLA), up 3.8% after reporting first quarter deliveries up 55% to 10,030 cars... Ariad (ARIA), up 3.4% following approval of Iclusig in Canada... Lumber Liquidators (LL), up 3.1% after being upgraded to Outperform from Market Perform at Raymond James. LOWER: Magnum Hunter (MHR), down 8.9% after being downgraded to Hold from Buy at Wunderlich... Herbalife (HLF), down following CNBC report that federal law enforcement agencies contacted the company regarding its business practices... Qualcomm (QCOM), down 2.2% following a Wall Street Journal report that the Samsung (SSNLF) Galaxy S6 did not have a Qualcomm LTE modem... Skyworks (SWKS), down 2.1% after being downgraded to Equal Weight from Overweight at Stephens.
09:02 EDTTSLATesla trades up on Q1 deliveries update, levels to watch
Subscribe for More Information
08:57 EDTCTRXCatamaran downgraded to Market Perform from Outperform at BMO Capital
Subscribe for More Information
08:41 EDTTSLARW Baird calls Tesla favorite pick after Q1 deliveries beat expectations
Baird said they would be buyers of Tesla and the stock remains their favorite pick following the company's announcement of Q1 deliveries of 10,030 vehicles, which beat both the Street and firm's estimates. The firm also noted the company's reporting change to "within three days" of the end of the quarter, as it erases the month of speculation between quarter end and reporting. Baird reiterated its Outperform rating and $275 price target on Tesla shares.
08:24 EDTTSLATesla Q1 deliveries not impressive, says BofA/Merrill
Subscribe for More Information
07:57 EDTCTRXLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Gupte discusses the leverage Anthem likely has in its Pharmacy Benefit Manager (PBM) contract with Express Scripts and how it changes after the Catamaran-Optum Rx deal, the synergy potential for the deal between Catamaran and Optum Rx and the likelihood of Cigna-HS remaining with the newly merged Optum Rx-CTRX on an Analyst/Industry conference call to be held on April 6 at 2 pm.
07:43 EDTTRIPTripAdvisor downgraded to Hold from Buy at Needham
Needham downgraded TripAdvisor to Hold citing the unexpected resignation of CFO Julie Bradley. The analyst said the departure creates uncertainty and may indicate Q1 was weaker than expected.
07:29 EDTAAPLApple Watch cannot launch in Switzerland due to patent issue, Reuters says
Subscribe for More Information
06:20 EDTAAPLGarmin downgraded to Sell from Buy at Citigroup
Citigroup analyst Jeremy David downgraded Garmin two notches to Sell from Buy saying competitive pressures are likely to stall the growth of the company's GPS fitness watch business. He also thinks revenue trends in Garmin's Outdoor segment could disappoint as the year progresses. David expects Garmin to miss consensus earnings and revenue expectations in Q1 and views the Apple (AAPL) Watch launch as another potential negative catalyst for shares. He cut his price target for the stock to $42 from $68. Shares of the navigation and information device maker closed Thursday down 58c to $46.49 after Goldman Sachs downgraded the stock Neutral from Buy.
06:11 EDTAAPLSamsung expected to win A9 chip orders for next iPhone, Bloomberg reports
Subscribe for More Information
06:00 EDTAMZNIndian railways may tie up with Amazon for parcels, Economic Times says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use